Position in TLRY
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$97,703
New position
Shares Held
15,101
first reported quarter
Ownership
0.013%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Swiss Life Asset Management Ltd holds $41,003,042 across 18 Drug Manufacturers - Specialty & Generic names. TLRY ranks #16 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
174,361 | $20,611,212 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
15,776 | $9,354,852 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
101,990 | $3,071,938 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
20,740 | $2,732,287 | |
| 5 | VTRS |
Viatris Inc
|
100,279 | $1,354,769 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
44,011 | $1,053,183 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
19,034 | $580,156 | |
| 8 | PBH |
Prestige Consumer Healthcare Inc.
|
5,872 | $348,033 |
All Filings in TLRY
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $97,703 | 15,101 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||